Arkolith/Insider Trading/PBSV/Form 4

Wiesen Irving L

DirectorPharma-Bio Serv, Inc. (PBSV) · full profile →Form 4 · filed Jan 5, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 4, 2022Option exercise(M)20K$0.91$18K52K
Jan 4, 2022Tax withholding(F)10K$1.03$10K44K
Jan 4, 2022Option exercise(M)20K$0.52$10K54K
Jan 4, 2022Tax withholding(F)18K$1.03$18K34K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 4, 2022Option exercise(M)20K—$00
Jan 4, 2022Option exercise(M)20K—$00

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001654954-22-000249) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML